Survival and recurrences after hepatic resection or radiofreauency for hepatocellular carcinoma in cirrhotic patients: A multivariate analysis

被引:101
作者
Montorsi, M
Santambrogio, R
Bianchi, P
Donadon, M
Moroni, E
Spinelli, A
Costa, M
机构
[1] Univ Milan, Sch Med, Ist Clin Humanitas, Dept Gen Surg, Milan, Italy
[2] Azienda Osped San Paolo, Dept Surg, Milan, Italy
关键词
hepatocellular carcinoma; hepatic cirrhosis; hepatic resection; hepatic tumor ablation; laparoscopic radiofrequency;
D O I
10.1016/j.gassur.2004.10.003
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatic resection is still considered the treatment of choice for hepatocellular carcinoma in patients with liver cirrhosis. Radiofrequency ablation is a new emerging modality. The aim of this study was to compare two homogeneous groups of patients who underwent either surgical resection or laparoscopic radiofrequency, analyzing the factors predicting survival and intrahepatic recurrences with use of a multivariate analysis. From February 1997 to April 2003, 98 patients were enrolled in this prospective study. Inclusion criteria were a single nodule of less than 5 cm, Child A-B class of liver function, and no previous treatment: 40 patients were in the surgical group and 58 patients were in the radiofrequency group. The two groups were homogeneous as far as preoperative characteristics were concerned. Operative mortality was zero, and the rates of operative morbidity were similar. Actuarial survival at 4 years was not significantly different (61% after resection and 45% after radiofrequency). There was a significant higher incidence of intrahepatic recurrences after radiofrequency than after resection (53% versus 30%; P = 0.018). This was mainly due to local recurrences, whereas those appearing in other liver segments were similar in both groups. A multivariate analysis showed that the significant factors predictive of an intrahepatic recurrence were the level of a-fetoprotein, the etiology of cirrhosis, and the type of the treatment. On the other hand, multivariate analysis of the survival showed that only the level of alpha-fetoprotein was an independent predictor of survival. The results of our study showed a significant lower incidence of intrahepatic recurrences after resection compared with after radiofrequency. This seems not to significantly influence the overall survival, probably because of a prompt and effective treatment of the recurrences themselves. (C) 2005 The Society for Surgery of the Alimentary Tract
引用
收藏
页码:62 / 67
页数:6
相关论文
共 26 条
[1]   Clinical management of hepatocellular carcinoma.: Conclusions of the Barcelona-2000 EASL Conference [J].
Bruix, J ;
Sherman, M ;
Llovet, JM ;
Beaugrand, M ;
Lencioni, R ;
Burroughs, AK ;
Christensen, E ;
Pagliaro, L ;
Colombo, M ;
Rodés, J .
JOURNAL OF HEPATOLOGY, 2001, 35 (03) :421-430
[2]   A new prognostic classification for predicting survival in patients with hepatocellular carcinoma [J].
Chevret, S ;
Trinchet, JC ;
Mathieu, D ;
Rached, AA ;
Beaugrand, M ;
Chastang, C .
JOURNAL OF HEPATOLOGY, 1999, 31 (01) :133-141
[3]  
Chung MH, 2001, SURG ENDOSC-ULTRAS, V15, P1020
[4]  
COX DR, 1972, J R STAT SOC B, V34, P187
[5]  
Hanazaki K, 2001, AM J GASTROENTEROL, V96, P1243, DOI 10.1111/j.1572-0241.2001.03634.x
[6]   Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma [J].
Harrison, LE ;
Koneru, B ;
Baramipour, P ;
Fisher, A ;
Barone, A ;
Wilson, D ;
Dela Torre, A ;
Cho, KC ;
Contractor, D ;
Korogodsky, M .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2003, 197 (05) :759-764
[7]   Treatment strategies for hepatocellular carcinoma in cirrhosis [J].
Helton, WS ;
Di Bisceglie, A ;
Chari, R ;
Schwartz, M ;
Bruix, J .
JOURNAL OF GASTROINTESTINAL SURGERY, 2003, 7 (03) :401-411
[8]   Risk factors contributing to early and date phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy [J].
Imamura, H ;
Matsuyama, Y ;
Tanaka, E ;
Ohkubo, T ;
Hasegawa, K ;
Miyagawa, S ;
Sugawara, Y ;
Minagawa, M ;
Takayama, T ;
Kawasaki, S ;
Makuuchi, M .
JOURNAL OF HEPATOLOGY, 2003, 38 (02) :200-207
[9]   Hepatocellular carcinoma: is current therapy really altering outcome? [J].
Johnson, PJ .
GUT, 2002, 51 (04) :459-462
[10]   The influence on liver parenchymal function and complications of radiofrequency ablation or the combination with transcatheter arterial embolization for hepatocellular carcinoma [J].
Koda, M ;
Ueki, M ;
Maeda, Y ;
Mimura, KI ;
Okamoto, K ;
Matsunaga, Y ;
Kawakami, M ;
Hosho, K ;
Murawaki, Y .
HEPATOLOGY RESEARCH, 2004, 29 (01) :18-23